Real-world Evidence Shows Good Acceptance of Rituximab Biosimilar for NHL, CLL

Retrieved on: 2021-08-05 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Real-world Evidence Shows Good Acceptance of Rituximab Biosimilar for NHL, CLL. View article details on hiswai:

Excerpt

Prior to rituximab-pvvr treatment, 48.7% of the patients with NHL received chemotherapy, and 42.5% received either reference rituximab or another ...

Article found on: www.ajmc.com